CD34 and hepatocellular carcinoma: In vitro experiments showed that stable knockout of ANXA5 reduced the proliferation, migration, invasion, and lymph node adhesion of hepatoma Hca-P cells by inhibiting CD34 and VEGF3 increased the adhesion behavior between cells, and reduced tumorigenicity and malignant tumorigenesis in mice (28).